Evidence map›Paper›PMID 41359629›Full record

ArticlePloS one2025

Stakeholder communication and client understanding of viral load suppression in Blantyre, Malawi-What role did U = U play before the flip the script campaign?

Astrid Berner-Rodoreda, Boniface Chione, Esther Ngwira, Rosalia Dambe, Sam Phiri, Till Bärnighausen, Yussif Alhassan, Miriam Taegtmeyer, Petros Tembo, Caryl Feldacker and 2 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Astrid Berner-RodoredaHeidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-5484-890X
Boniface ChioneThe Lighthouse Trust, Blantyre and Lilongwe, Malawi.
Esther NgwiraLilongwe University of Agriculture and Natural Resources, Lilongwe, Malawi.
Rosalia DambeMeharry Medical College Global Health and HIV Clinical Services, Blantyre, Malawi.
Sam PhiriPartners in Hope, Lilongwe, Malawi.ORCID https://orcid.org/0000-0002-9372-212X
Till BärnighausenHeidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
Yussif AlhassanLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Miriam TaegtmeyerLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Petros TemboThe Lighthouse Trust, Blantyre and Lilongwe, Malawi.
Caryl FeldackerDepartment of Global Health, University of Washington, Seattle, United States of America.
Christine Kiruthu-KamamiaThe United Nations University, Maastricht Economic and Social Research Institute on Innovation and Technology, Maastricht, The Netherlands.
Florian NeuhannHeidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVarious studies have demonstrated the effectiveness of viral load suppression (VLS) in preventing sexual transmission of the human immunodeficiency virus (HIV), leading to the slogan "Undetectable = Untransmittable" or "U = U". As few studies have examined health stakeholders' understandings of U = U, the communication of a suppressed viral load (VL) to male clients, and male clients' understandings of the benefits of a suppressed VL in Sub-Saharan Africa, we explore these in this study. In the field of HIV, it is only in recent years that men who have sex with women (MSW) have been given some attention. The treatment cascade shows that MSW lag behind women in knowing their HIV-status, accessing treatment and suppressing their VL. METHODS AND

findingsOur findings are based on in-depth qualitative semi-structured in-person interviews with 16 local stakeholders (health facility personnel, NGO and church-based HIV programme implementers and applied researchers) and 39 men on antiretroviral treatment (ART) in Blantyre, Malawi: Twenty-three men with a detectable VL and 16 with a suppressed VL were included in the study. Thematic analysis of the audio-recorded and transcribed interviews show that stakeholders were mostly unfamiliar with the slogan U = U. Despite realizing the advantages for clients and their partners, stakeholders were cautious about how they conveyed information about an undetectable VL: they were worried about clients either misinterpreting an undetectable VL as being cured of HIV or engaging in risky sexual behaviour. This attitude prevailed irrespective of the degree of stakeholders' endorsement of the evidence of U = U. Male clients were aware of personal health benefits of a suppressed VL, yet unaware of their non-infectiousness. In order not to infect others, some men ceased sexual relations or forwent procreation.

conclusionFor U = U to become part of a client's actionable knowledge with regard to treatment benefits, U = U needs to be communicated comprehensively. To what extent recent policy changes, the Flip the Script campaign to make U = U known and staff training programs have led to a different practice will need to be further researched, using our findings as a reference point. Integrated health services are already in place; however, VL monitoring, and testing and treatment for sexually transmitted infections (STIs) should ideally be conducted more frequently than annually, so that Malawian clients can be assured of their VL status and of not passing on the virus while also being able to get any STIs treated.

Indexed as

Anti-HIV AgentsHIV InfectionsStakeholder ParticipationAdolescentAdultCommunicationFemaleHealth Knowledge, Attitudes, PracticeHumansImmunosuppression TherapyInterviews as TopicMalawiMaleMiddle AgedQualitative ResearchSexual BehaviorAnti-HIV Agents

Identifiers

PMID41359629
PMCPMC12685186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.